Industry Research Reports

Home > Reports > Medical Devices & Consumables > Diagnostic Kit for Quantification of Hepatitis C Virus RNA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Diagnostic Kit for Quantification of Hepatitis C Virus RNA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 130 Pages

Report ld: 3499368

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Size(US$)

CAGR 2025-2031

3.5%

Market Size,2031

USD 82.4

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 67 million

Market Forecast in 2031(Value)

US$ 82.4 million

CAGR

3.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Diagnostic Kit for Quantification of Hepatitis C Virus RNA was estimated to be worth US$ 65 million in 2024 and is forecast to a readjusted size of US$ 82.4 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.

Hepatitis C virus (HCV) is a global infectious pathogen that can cause acute and chronic viral hepatitis. The Hepatitis C Virus PCR Diagnostic Kit is a high sensitivity real-time reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the detection and quantification of HCV specific RNA in human serum and plasma.

With continuous advancements in medical technology, the Diagnostic Kit for Quantification of Hepatitis C Virus RNA has emerged as a pivotal tool for diagnosing and monitoring Hepatitis C. This diagnostic kit enables highly accurate measurement of the quantity of Hepatitis C virus RNA within a patient"s body, aiding doctors in assessing the severity of the condition and devising personalized treatment strategies. As the number of individuals infected with Hepatitis C virus continues to rise, there is a growing demand for high-quality and dependable RNA quantification diagnostic kits. Consequently, the market for such diagnostic kits is expected to experience sustained and stable growth in the coming years.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Kit for Quantification of Hepatitis C Virus RNA, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diagnostic Kit for Quantification of Hepatitis C Virus RNA by region & country, by Type, and by Application.

The Diagnostic Kit for Quantification of Hepatitis C Virus RNA market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Kit for Quantification of Hepatitis C Virus RNA.

MARKET SEGMENTATION

By Company

Abbott
Siemens Healthineers
altona Diagnostics
GeneProof
Roche Diagnostics
3B BlackBio Biotech India Limited
Biogerm Medical
Liferiver
Rendu Biotechnology
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Ultra-sensitive
High Sensitivity
General Sensitivity

Segment by Application

Hospital
Clinic
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Diagnostic Kit for Quantification of Hepatitis C Virus RNA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Diagnostic Kit for Quantification of Hepatitis C Virus RNA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Diagnostic Kit for Quantification of Hepatitis C Virus RNA in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Introduction

1.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Size Forecast

1.2.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value (2020-2031)

1.2.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume (2020-2031)

1.2.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Price (2020-2031)

1.3 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Trends & Drivers

1.3.1 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Industry Trends

1.3.2 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Drivers & Opportunity

1.3.3 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Challenges

1.3.4 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Players Revenue Ranking (2024)

2.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Revenue by Company (2020-2025)

2.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Players Sales Volume Ranking (2024)

2.4 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Company Players (2020-2025)

2.5 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Average Price by Company (2020-2025)

2.6 Key Manufacturers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Manufacturing Base and Headquarters

2.7 Key Manufacturers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Diagnostic Kit for Quantification of Hepatitis C Virus RNA

2.9 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Competitive Analysis

2.9.1 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Diagnostic Kit for Quantification of Hepatitis C Virus RNA Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Kit for Quantification of Hepatitis C Virus RNA as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Ultra-sensitive

3.1.2 High Sensitivity

3.1.3 General Sensitivity

3.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type

3.2.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, by Type (2020-2031)

3.2.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, by Type (%) (2020-2031)

3.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Type

3.3.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, by Type (2020-2031)

3.3.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, by Type (%) (2020-2031)

3.4 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Other

4.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application

4.2.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, by Application (2020-2031)

4.2.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, by Application (%) (2020-2031)

4.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Application

4.3.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, by Application (2020-2031)

4.3.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, by Application (%) (2020-2031)

4.4 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region

5.1.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (2020-2025)

5.1.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (2026-2031)

5.1.4 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (%), (2020-2031)

5.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region

5.2.1 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (2020-2025)

5.2.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (2026-2031)

5.2.4 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (%), (2020-2031)

5.3 Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

5.4.2 North America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

5.5.2 Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

5.6.2 Asia Pacific Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

5.7.2 South America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

5.8.2 Middle East & Africa Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value

6.2.1 Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.2.2 Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.3.2 United States Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.4.2 Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.5.2 China Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.5.3 China Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.6.2 Japan Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.7.2 South Korea Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.8.2 Southeast Asia Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020-2031

6.9.2 India Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

6.9.3 India Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Abbott

7.1.1 Abbott Company Information

7.1.2 Abbott Introduction and Business Overview

7.1.3 Abbott Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Abbott Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.1.5 Abbott Recent Development

7.2 Siemens Healthineers

7.2.1 Siemens Healthineers Company Information

7.2.2 Siemens Healthineers Introduction and Business Overview

7.2.3 Siemens Healthineers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Siemens Healthineers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.2.5 Siemens Healthineers Recent Development

7.3 altona Diagnostics

7.3.1 altona Diagnostics Company Information

7.3.2 altona Diagnostics Introduction and Business Overview

7.3.3 altona Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 altona Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.3.5 altona Diagnostics Recent Development

7.4 GeneProof

7.4.1 GeneProof Company Information

7.4.2 GeneProof Introduction and Business Overview

7.4.3 GeneProof Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 GeneProof Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.4.5 GeneProof Recent Development

7.5 Roche Diagnostics

7.5.1 Roche Diagnostics Company Information

7.5.2 Roche Diagnostics Introduction and Business Overview

7.5.3 Roche Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Roche Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.5.5 Roche Diagnostics Recent Development

7.6 3B BlackBio Biotech India Limited

7.6.1 3B BlackBio Biotech India Limited Company Information

7.6.2 3B BlackBio Biotech India Limited Introduction and Business Overview

7.6.3 3B BlackBio Biotech India Limited Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 3B BlackBio Biotech India Limited Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.6.5 3B BlackBio Biotech India Limited Recent Development

7.7 Biogerm Medical

7.7.1 Biogerm Medical Company Information

7.7.2 Biogerm Medical Introduction and Business Overview

7.7.3 Biogerm Medical Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Biogerm Medical Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.7.5 Biogerm Medical Recent Development

7.8 Liferiver

7.8.1 Liferiver Company Information

7.8.2 Liferiver Introduction and Business Overview

7.8.3 Liferiver Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Liferiver Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.8.5 Liferiver Recent Development

7.9 Rendu Biotechnology

7.9.1 Rendu Biotechnology Company Information

7.9.2 Rendu Biotechnology Introduction and Business Overview

7.9.3 Rendu Biotechnology Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Rendu Biotechnology Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.9.5 Rendu Biotechnology Recent Development

7.10 Sansure Biotech

7.10.1 Sansure Biotech Company Information

7.10.2 Sansure Biotech Introduction and Business Overview

7.10.3 Sansure Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Sansure Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.10.5 Sansure Biotech Recent Development

7.11 Daan Gene

7.11.1 Daan Gene Company Information

7.11.2 Daan Gene Introduction and Business Overview

7.11.3 Daan Gene Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Daan Gene Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.11.5 Daan Gene Recent Development

7.12 BGI Group

7.12.1 BGI Group Company Information

7.12.2 BGI Group Introduction and Business Overview

7.12.3 BGI Group Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 BGI Group Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.12.5 BGI Group Recent Development

7.13 Abiores

7.13.1 Abiores Company Information

7.13.2 Abiores Introduction and Business Overview

7.13.3 Abiores Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Abiores Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.13.5 Abiores Recent Development

7.14 ACON Biotech

7.14.1 ACON Biotech Company Information

7.14.2 ACON Biotech Introduction and Business Overview

7.14.3 ACON Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 ACON Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

7.14.5 ACON Biotech Recent Development

8 Industry Chain Analysis

8.1 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Industrial Chain

8.2 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Model

8.5.2 Sales Channel

8.5.3 Diagnostic Kit for Quantification of Hepatitis C Virus RNA Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Trends

Table 2. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Drivers & Opportunity

Table 3. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Challenges

Table 4. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Restraints

Table 5. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Revenue Market Share by Company (2020-2025)

Table 7. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Manufacturing Base and Headquarters

Table 11. Key Manufacturers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Diagnostic Kit for Quantification of Hepatitis C Virus RNA

Table 13. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Kit for Quantification of Hepatitis C Virus RNA as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Value by Type (2020-2025)

Table 20. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Value by Type (2026-2031)

Table 21. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Value by Application (2020-2025)

Table 32. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Value by Application (2026-2031)

Table 33. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (2020-2025) & (%)

Table 44. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (2026-2031) & (%)

Table 45. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (2020-2025) & (%)

Table 49. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Region (2026-2031) & (%)

Table 50. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume, (2026-2031) & (K Units)

Table 57. Abbott Company Information

Table 58. Abbott Introduction and Business Overview

Table 59. Abbott Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Abbott Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 61. Abbott Recent Development

Table 62. Siemens Healthineers Company Information

Table 63. Siemens Healthineers Introduction and Business Overview

Table 64. Siemens Healthineers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Siemens Healthineers Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 66. Siemens Healthineers Recent Development

Table 67. altona Diagnostics Company Information

Table 68. altona Diagnostics Introduction and Business Overview

Table 69. altona Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. altona Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 71. altona Diagnostics Recent Development

Table 72. GeneProof Company Information

Table 73. GeneProof Introduction and Business Overview

Table 74. GeneProof Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. GeneProof Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 76. GeneProof Recent Development

Table 77. Roche Diagnostics Company Information

Table 78. Roche Diagnostics Introduction and Business Overview

Table 79. Roche Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Roche Diagnostics Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 81. Roche Diagnostics Recent Development

Table 82. 3B BlackBio Biotech India Limited Company Information

Table 83. 3B BlackBio Biotech India Limited Introduction and Business Overview

Table 84. 3B BlackBio Biotech India Limited Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. 3B BlackBio Biotech India Limited Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 86. 3B BlackBio Biotech India Limited Recent Development

Table 87. Biogerm Medical Company Information

Table 88. Biogerm Medical Introduction and Business Overview

Table 89. Biogerm Medical Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Biogerm Medical Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 91. Biogerm Medical Recent Development

Table 92. Liferiver Company Information

Table 93. Liferiver Introduction and Business Overview

Table 94. Liferiver Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Liferiver Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 96. Liferiver Recent Development

Table 97. Rendu Biotechnology Company Information

Table 98. Rendu Biotechnology Introduction and Business Overview

Table 99. Rendu Biotechnology Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Rendu Biotechnology Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 101. Rendu Biotechnology Recent Development

Table 102. Sansure Biotech Company Information

Table 103. Sansure Biotech Introduction and Business Overview

Table 104. Sansure Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Sansure Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 106. Sansure Biotech Recent Development

Table 107. Daan Gene Company Information

Table 108. Daan Gene Introduction and Business Overview

Table 109. Daan Gene Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Daan Gene Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 111. Daan Gene Recent Development

Table 112. BGI Group Company Information

Table 113. BGI Group Introduction and Business Overview

Table 114. BGI Group Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. BGI Group Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 116. BGI Group Recent Development

Table 117. Abiores Company Information

Table 118. Abiores Introduction and Business Overview

Table 119. Abiores Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. Abiores Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 121. Abiores Recent Development

Table 122. ACON Biotech Company Information

Table 123. ACON Biotech Introduction and Business Overview

Table 124. ACON Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. ACON Biotech Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Offerings

Table 126. ACON Biotech Recent Development

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Downstream Customers

Table 130. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Distributors List

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Product Picture

Figure 2. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume (2020-2031) & (K Units)

Figure 5. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Price (2020-2031) & (US$/Unit)

Figure 6. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Report Years Considered

Figure 7. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diagnostic Kit for Quantification of Hepatitis C Virus RNA Revenue in 2024

Figure 10. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Ultra-sensitive Picture

Figure 12. High Sensitivity Picture

Figure 13. General Sensitivity Picture

Figure 14. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value Market Share by Type, 2024 & 2031

Figure 16. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 17. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume Market Share by Type, 2024 & 2031

Figure 18. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Type (2020-2031) & (US$/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Clinic

Figure 21. Product Picture of Other

Figure 22. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 25. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Price by Application (2020-2031) & (US$/Unit)

Figure 27. North America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Volume (%), (2020-2031)

Figure 39. United States Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 45. China Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 47. China Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 57. India Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Type (%), 2024 VS 2031

Figure 59. India Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Value by Application (%), 2024 VS 2031

Figure 60. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Industrial Chain

Figure 61. Diagnostic Kit for Quantification of Hepatitis C Virus RNA Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Diagnostic Kit for Quantification of Hepatitis C Virus RNA in 2025? zhanKai

The global market size of Diagnostic Kit for Quantification of Hepatitis C Virus RNA in 2025 was 67 Million USD.

Which companies rank high in the global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market size from 2025 to 2031? shouQi

What was the global market size of Diagnostic Kit for Quantification of Hepatitis C Virus RNA in 2031? shouQi

Related Reports

Diagnostic Kit for Quantification of Hepatitis C Virus RNA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diagnostic Kit for Quantification of Hepatitis C Virus RNA was estimated to be worth US$ 67.03 million in 2025 and is projected to reach US$ 84.99 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 136
USD 3950.00
(Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2026
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market was valued at US$ 67.03 million in 2025 and is anticipated to reach US$ 84.99 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 123
USD 2900.00
(Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market size was US$ 65 million in 2024 and is forecast to a readjusted size of US$ 82.4 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market is projected to grow from US$ 65 million in 2024 to US$ 82.4 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 169
USD 4900.00
(Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2025
The global market for Diagnostic Kit for Quantification of Hepatitis C Virus RNA was valued at US$ 65 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2024
Hepatitis C virus (HCV) is a global infectious pathogen that can cause acute and chronic viral hepatitis. The Hepatitis C Virus PCR Diagnostic Kit is a high sensitivity real-time reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the detection and quantification of HCV specific RNA in human serum and plasma.
Published Date: 2024-01-17
Pages: 92
USD 2900.00
(Single User License)

Diagnostic Kit for Quantification of Hepatitis C Virus RNA- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diagnostic Kit for Quantification of Hepatitis C Virus RNA was estimated to be worth US$ 67.03 million in 2025 and is projected to reach US$ 84.99 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 136
USD 3950.00 (Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2026
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market was valued at US$ 67.03 million in 2025 and is anticipated to reach US$ 84.99 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 123
USD 2900.00 (Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market size was US$ 65 million in 2024 and is forecast to a readjusted size of US$ 82.4 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
USD 4250.00 (Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market is projected to grow from US$ 65 million in 2024 to US$ 82.4 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 169
USD 4900.00 (Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2025
The global market for Diagnostic Kit for Quantification of Hepatitis C Virus RNA was valued at US$ 65 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-01-13
Pages: 89
USD 2900.00 (Single User License)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Research Report 2024
Hepatitis C virus (HCV) is a global infectious pathogen that can cause acute and chronic viral hepatitis. The Hepatitis C Virus PCR Diagnostic Kit is a high sensitivity real-time reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the detection and quantification of HCV specific RNA in human serum and plasma.
Published: 2024-01-17
Pages: 92
USD 2900.00 (Single User License)